Kenji Terashi

Direct Interaction between a Quinoline Derivative, MS-209, and Multidrug Resistance Protein (MRP) in Human Gastric Cancer Cells

Takashi Nakamura, Mikio Oka, Kikuo Aizawa et al. · Biochemical and Biophysical Research Communications · 1999 · 62 citations

Biochemistry, Medicine, Direct Interaction +7

Close Association between Clearance of Recombinant Human Granulocyte Colony-Stimulating Factor (G-CSF) and G-CSF Receptor on Neutrophils in Cancer Patients

Kenji Terashi, Mikio Oka, Shigehiro Ohdo et al. · Antimicrobial Agents and Chemotherapy · 1999 · 44 citations · Full text

Immunology, Blood Cell, Pathology +18

Phase I study of irinotecan combined with carboplatin in previously untreated solid cancers.

M Fukuda, Masaaki Oka, Hiroshi Soda et al. · PubMed · 1999 · 42 citations

Chatelut Formula, Carboplatin Dose, Medicine +11

The Multidrug Resistance‐associated Protein Gene Confers Drug Resistance in Human Gastric and Colon Cancers

Michio Tomonaga, Mikio Oka, Fumihiko Narasaki et al. · Japanese Journal of Cancer Research · 1996 · 39 citations · Full text

Drug Target, Pathology, Cancer Biology +17

A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene

Fumihiko Narasaki, Mikio Oka, Minoru Fukuda et al. · Cancer Chemotherapy and Pharmacology · 1997 · 33 citations

Novel Quinoline Derivative, Drug Resistance Analysis, Medicine +7